Combined Pancreas and Kidney Transplantation in a Lean Type 2 Diabetic Patient. Effects on Insulin Secretion and Sensitivity

 

 Buy Article Permissions and Reprints

Summary

Background/aims: Pancreas transplantation is an established method of treating Type 1 diabetes. It was our aim to test the consequences of pancreas transplantation in a Type 2 diabetic patient by determining insulin secretion and sensitivity before and after surgery.

Patients and methods: A female patient with Type 2 diabetes and end-stage nephropathy was treated with combined pancreas and kidney transplantation. Before surgery and at 4 weeks, 6 months and 2 years afterwards, insulin sensitivity was measured using hyperinsulinemic euglycemic clamps and insulin secretion was quantified after oral glucose or intravenous glucagon challenges.

Results: The patient was insulin resistant before surgery (glucose infusion 4.6 mg · kg^-1 · min^-1, normal range 6.4 ± 0.5 mg ·kg^-1 · min^-1). Insulin sensitivity declined further after transplantation (1.4 and 3.0 mg · kg^-1 · min^-1 after 4 weeks and 6 months, respectively), but improved to 5.4 mg · kg^-1 · min^-1 after 2 years. Insulin secretion was greatly impaired before surgery. Insulin and C-peptide responses after oral glucose and intravenous glucagon increased into the normal range from 6 months after surgery onwards and oral glucose tolerance remained non-diabetic (IGT).

Conclusions: Insulin resistance is first aggravated after pancreas transplantation, probably due to immunosuppressive treatment including glucocorticoids, but improves on the long term. The initially impaired insulin secretion from the transplant may also be explained by the action of glucocorticoids or by transient and reversible organ damage.

References

• 1 Büsing M, Heimes M, Martin D, Schulz T, Dehof S, Kozuschek W. Simultaneous pancreas-/kidney transplantation - the Bochum experience.  Exp Clin Endocrinol Diabetes. 1997;  105 92-97
  PubMedGoogle Scholar
• 2 Christiansen E, Tibell A, Vølund A, Rasmussen K, Tyden G, Pedersen O, Christensen N J, Madsbad S. Insulin secretion, insulin action and non-insulin-dependent glucose uptake in pancreas transplant recipients.  J Clin Endocrinol Metab. 1994;  79 1561-1569
  CrossrefPubMedGoogle Scholar
• 3 Christiansen E, Tibell A, Vølund A A, Holst J J, Rasmussen K, Schaffer L, Madsbad S. Metabolism of oral glucose in pancreas transplant recipients with normal and impaired glucose tolerance.  J Clin Endocrinol Metab. 1997;  82 2299-2307
  CrossrefPubMedGoogle Scholar
• 4 Clark J DA, Wheatley T, Brons I GM, Bloom S R, Calne R Y. Studies on the entero-insular axis following pancreas transplantation in man: neural or hormonal control?.  Diabetic Med. 1989;  6 813-817
  PubMedGoogle Scholar
• 5 DeFronzo R A. The triumvirate: β-cell, muscle, liver: a collusion responsible for NIDDM.  Diabetes. 1991;  37 667-683
  PubMedGoogle Scholar
• 6 DeFronzo R A, Tobin J D, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance.  Am J Physiol (Endocrinol Metab). 3 1979; 
  PubMedGoogle Scholar
• 7 Delaunay F, Khan A, Cintra A, Davani B, Ling Z C, Andersson A, Östenson C G, Gustafsson J, Efendic S, Okret S. Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids.  J Clin Invest. 1997;  100 2094-2098
  CrossrefPubMedGoogle Scholar
• 8 Gruessner R W, Sutherland D E, Drangstveit M B, Troppmann C, Gruessner A C. Use of FK 506 in pancreas transplantation.  Transpl Int. 9 ((Suppl 1)) 1996;  S251-257
  PubMedGoogle Scholar
• 9 Hopt U T, Büsing M, Schareck W D, Becker H D. The bladder drainage technique in pancreas transplantation: The Tübingen experience.  Diabetologia. 34 ((Supp 1)) 1991;  24-28
  CrossrefPubMedGoogle Scholar
• 10 Lambillotte C, Gilon P, Henquin J-C. Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets.  J Clin Invest. 1997;  99 414-423
  CrossrefPubMedGoogle Scholar
• 11 Landgraf R. Impact of pancreas transplantation on diabetic secondary complications and quality of life.  Diabetologia. 1996;  39 1415-1424
  CrossrefPubMedGoogle Scholar
• 12 Landgraf R, Nusser J, Riepl R L, Fiedler F, Illner W D, Abendroth D, Land W. Metabolic and hormonal studies of type 1 (insulin-dependent) diabetic patients after successful pancreas and kidney transplantation.  Diabetologia. 34 ((Suppl 1)) 1991;  S61-67
  CrossrefPubMedGoogle Scholar
• 13 Luzi L, Secchi F, Facchini F, Battezzati A, Saudacher C, Spotti D, Castoldi R, Ferrari G, Di Carlo V, Pozza G. Reduction of insulin resistance by combined kidney-pancreas transplantation in type 1 (insulin-dependent) diabetic patients.  Diabetologia. 1990;  33 549-556
  CrossrefPubMedGoogle Scholar
• 14 Nauck M A, Blietz R W, Qualmann C. Comparison of hyperinsulinaemic clamp experiments using venous, “arterialized” venous or capillary euglycaemia.  Clin Physiol. 1996;  16 589-602
  PubMedGoogle Scholar
• 15 Nauck M A, Büsing M, Ørskov C, Siegel E G, Talartschik J, Baartz A, Baartz T, Hopt U T, Becker H-D, Creutzfeldt W. Preserved incretin effect in type 1 diabetic patients with end-stage nephropathy treated by combined heterotopic pancreas and kidney transplantation.  Acta Diabetol. 1993;  30 39-45
  CrossrefPubMedGoogle Scholar
• 16 Pfeffer F, Nauck M A, Benz S, Gwodzinski A, Zink R, Busing M, Becker H D, Hopt U T. Determinants of a normal (versus impaired) oral glucose tolerance after combined pancreas-kidney transplantation in IDDM patients.  Diabetologia. 1996;  39 462-468
  PubMedGoogle Scholar
• 17 Ratner R, Gray R S, Robbins D, Sasaki T, Light J. Effect of combined kidney-pancreas transplantation (KP-Tx) on insulin secretion and insulin action in patients with NIDDM (abstract).  Diabetes. 45 ((Suppl 2)) 1996;  23A
  PubMedGoogle Scholar
• 18 Ratner R E, Gray R S, Sasaki T, Light J A. Combined kidney-pancreas transplantation in patients with unrecognized NIDDM (abstract).  Diabetologia. 39 ((Suppl 1)) 1996;  A132
  PubMedGoogle Scholar
• 19 Robertson R P, Olson L K, Zhang H-J. Differentiating glucose toxicity from glucose desensitization: A new message from the insulin gene.  Diabetes. 1994;  43 1085-1089
  PubMedGoogle Scholar
• 20 Robertson R P, Sutherland D E, Kendall D M, Teuscher A U, Gruessner R W, Gruessner A. Metabolic characterization of long-term successful pancreas transplants in type I diabetes.  J Investig Med. 1996;  44 549-555
  PubMedGoogle Scholar
• 21 Sasaki T M, Gray R S, Ratner R E, Currier C, Aquino A, Barhyte D Y, Light J A. Successful long-term kidney-pancreas transplants in diabetic patients with high C-peptide levels.  Transplantation. 1998;  65 1510-1512
  PubMedGoogle Scholar
• 22 Schmitz O, Alberti K GMM, Christensen N J, Hasling C, Hjøllund E, Beck-Nielsen H, Ørskov H. Aspects of glucose homeostasis in uremia as assessed by the hyperinsulinemic euglycemic clamp technique.  Metabolism. 1985;  34 465-473
  CrossrefPubMedGoogle Scholar
• 23 Shapiro A MJ, Lakey J RT, Ryan E A, Korbutt G S, Toth E, Warnock G L, Kneteman N M, Rajotte R V. Islet transplantation in seven patients with type 2 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.  N Engl J Med. 2000;  343 230-238
  CrossrefPubMedGoogle Scholar
• 24 Stegall M, Wachs M, Kam I. Successful pancreas transplantation in adult-onset diabetes mellitus (AODM) (abstract).  Diabetes. 46 ((Suppl 1)) 1997;  64A
  PubMedGoogle Scholar
• 25 Sutherland D E. Pancreas and islet cell transplantation: now and then.  Transplant Proc. 1996;  28 2131-2133
  PubMedGoogle Scholar
• 26 Sutherland D ER. Pancreas transplantation: Indications and outcomes.  Acta Diabetol. 1992;  28 185-188
  CrossrefPubMedGoogle Scholar

Prof. Dr. med. Michael A. Nauck

Diabeteszentrum Bad Lauterberg

Kirchberg 21

37431 Bad Lauterberg im Harz

Germany

Phone: + 49-5524-81218

Fax: + 49-5524-81398

Email: M.Nauck@diabeteszentrum.de